Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F3TYF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $75,298
Award facts
- Contract value 100% obligated
- $75,297.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $75,297.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injector pharmaceutical supplies. The contract, awarded on January 20, 2026, with an ultimate completion date of January 21, 2026, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. This award was made on a competitive, non-set-aside basis, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. The parent organization, Cencora, Inc. (doing business as AmerisourceBergen), serves as a critical pharmaceutical distributor for federal healthcare systems.
ENBREL is a biologic medication used to treat inflammatory conditions including rheumatoid arthritis and other autoimmune disorders, commonly prescribed within military and veteran healthcare systems supported by the Defense Health Agency and DLA. This delivery order exemplifies AmerisourceBergen's role as a primary pharmaceutical vendor supplying essential medications and medical devices across multiple therapeutic domains to support military treatment facilities and federal healthcare programs globally. The contractor's extensive portfolio of federal contracts demonstrates its capability to efficiently fulfill government procurement requirements for both specialty and general pharmaceutical products on a competitive basis.
Quick answers
Who was awarded contract SPE2DR26F3TYF?
SPE2DR26F3TYF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F3TYF worth?
The government has obligated $75,298 on SPE2DR26F3TYF.
Is contract SPE2DR26F3TYF an order under another contract?
Yes. SPE2DR26F3TYF is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3TYF competed?
The extent of competition for SPE2DR26F3TYF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award